Medpace Holdings, Inc is a diagnostics & research business based in the US. Medpace shares (MEDP) are listed on the NASDAQ and all prices are listed in US Dollars. Medpace employs 3,900 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Medpace
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MEDP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Medpace stock price (NASDAQ: MEDP)Use our graph to track the performance of MEDP stocks over time.
Medpace shares at a glance
|Latest market close||$167.06|
|52-week range||$105.48 - $196.12|
|50-day moving average||$178.68|
|200-day moving average||$164.80|
|Wall St. target price||$181.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$4.22|
Buy Medpace shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Medpace stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Medpace price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||-7.32%|
|3 months (2021-04-26)||-14.02%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Is Medpace under- or over-valued?
Valuing Medpace stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medpace's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medpace's P/E ratio
Medpace's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, Medpace shares trade at around 43x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Medpace's PEG ratio
Medpace's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.97. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medpace's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Medpace's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $199.3 million.
The EBITDA is a measure of a Medpace's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$955 million|
|Operating margin TTM||18.76%|
|Gross profit TTM||$571.5 million|
|Return on assets TTM||8.65%|
|Return on equity TTM||20.26%|
|Market capitalisation||$6.6 billion|
TTM: trailing 12 months
Shorting Medpace shares
There are currently 595,622 Medpace shares held short by investors – that's known as Medpace's "short interest". This figure is 10.8% down from 668,099 last month.
There are a few different ways that this level of interest in shorting Medpace shares can be evaluated.
Medpace's "short interest ratio" (SIR)
Medpace's "short interest ratio" (SIR) is the quantity of Medpace shares currently shorted divided by the average quantity of Medpace shares traded daily (recently around 172145.0867052). Medpace's SIR currently stands at 3.46. In other words for every 100,000 Medpace shares traded daily on the market, roughly 3460 shares are currently held short.
However Medpace's short interest can also be evaluated against the total number of Medpace shares, or, against the total number of tradable Medpace shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medpace's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Medpace shares in existence, roughly 20 shares are currently held short) or 0.0205% of the tradable shares (for every 100,000 tradable Medpace shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Medpace.
Find out more about how you can short Medpace stock.
Medpace share dividends
We're not expecting Medpace to pay a dividend over the next 12 months.
Medpace share price volatility
Over the last 12 months, Medpace's shares have ranged in value from as little as $105.48 up to $196.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medpace's is 1.343. This would suggest that Medpace's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Stocks similar to Medpace
Medpace in the news
Medpace Holdings Inc (MEDP) President & CEO August J. Troendle Sold $3.5 million of Shares
Medpace Holdings Inc (MEDP) President & CEO August J. Troendle Sold $2.5 million of Shares
Medpace price target raised to $205 from $200 at Credit Suisse
Frequently asked questionsWhat percentage of Medpace is owned by insiders or institutions?
Currently 20.55% of Medpace shares are held by insiders and 80.082% by institutions. How many people work for Medpace?
Latest data suggests 3,900 work at Medpace. When does the fiscal year end for Medpace?
Medpace's fiscal year ends in December. Where is Medpace based?
Medpace's address is: 5375 Medpace Way, Cincinnati, OH, United States, 45227 What is Medpace's ISIN number?
Medpace's international securities identification number is: US58506Q1094 What is Medpace's CUSIP number?
Medpace's Committee on Uniform Securities Identification Procedures number is: 58506Q109
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert